GEN Exclusives

More »

GEN News Highlights

More »
May 20, 2008

BD to Leverage Accelr8’s BACcel Diagnostic Tool

  • BD intends to fund a research program at Accelr8 until September 30, 2009, under an agreement covering Accelr8’s BACcel™ pathogen diagnostics platform. BD-backed activities at Accelr8 will support BD’s product development in the diagnostics arena.

    BD holds the option to exclusively license Accelr8’s intellectual property in the field of infectious diseases diagnostics. Accelr8 retains commercialization rights for other applications.

    If BD exercises the option during or at the conclusion of the research program, the firm will have to pay an initial fee and running royalties on covered products. Under the license, BD will fund and conduct all product development, manufacturing, and marketing.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Using CRISPRs to Tame GMOs

With more climate-induced droughts and insect infestations on the horizon do you think technologies like CRISPR will change a lot of people’s minds about GMOs, including genetically engineered foods?

More »